Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
説明 | FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia. |
分子量 | 562.66 |
分子式 | C24H30N6O6S2 |
CAS No. | 2671128-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (435.43 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FHD-286 2671128-05-3 Chromatin/Epigenetic Epigenetic Reader Domain Inhibitor inhibit FHD 286 FHD286 inhibitor